A NEW PROSPECT FOR WEIGHT CONTROL ?

Experts are rapidly focused on retatrutide, a promising treatment developed by Eli Lilly, as a possible breakthrough in weight loss . Unlike many existing approaches, retatrutide is a dual -action receptor targeting equally GLP-1 and GIP, hormones that impact satiety and glucose regulation . Pre